🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the producers of Tylenol, claiming the corporations hid safety concerns that the drug presented to children's neurological development.

The court filing follows four weeks after Former President Trump promoted an unsubstantiated connection between taking acetaminophen - alternatively called paracetamol - during pregnancy and autism in offspring.

Paxton is suing Johnson & Johnson, which once produced the medication, the sole analgesic recommended for expectant mothers, and the current manufacturer, which presently makes it.

In a declaration, he stated they "betrayed America by profiting off of suffering and promoting medication without regard for the dangers."

The manufacturer says there is lacking scientific proof linking acetaminophen to autism spectrum disorder.

"These manufacturers misled for generations, intentionally threatening numerous people to line their pockets," Paxton, a Republican, said.

Kenvue stated officially that it was "deeply concerned by the perpetuation of misinformation on the safety of paracetamol and the likely effects that could have on the welfare of women and children in America."

On its online platform, the company also said it had "regularly reviewed the applicable studies and there is insufficient valid information that shows a proven link between taking acetaminophen and autism spectrum disorder."

Organizations speaking for physicians and medical practitioners share this view.

The leading OB-GYN organization has declared acetaminophen - the key substance in acetaminophen - is a restricted selection for expectant mothers to address discomfort and fever, which can create significant medical dangers if left untreated.

"In over twenty years of investigation on the use of paracetamol in gestation, not a single reputable study has successfully concluded that the usage of paracetamol in any trimester of gestation results in brain development issues in offspring," the organization stated.

The lawsuit mentions latest statements from the Trump administration in arguing the medication is potentially dangerous.

In recent weeks, Trump generated worry from public health officials when he instructed women during pregnancy to "resist strongly" not to take acetaminophen when ill.

The US Food and Drug Administration then published an announcement that medical professionals should contemplate reducing the use of acetaminophen, while also declaring that "a direct connection" between the medication and autism in children has remains unverified.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had promised in April to undertake "extensive scientific investigation" that would establish the origin of autism spectrum disorder in a limited time.

But experts cautioned that identifying a single cause of autism - considered by experts to be the outcome of a intricate combination of genetic and surrounding conditions - would prove challenging.

Autism spectrum disorder is a type of enduring cognitive variation and impairment that affects how persons perceive and interact with the surroundings, and is recognized using doctors' observations.

In his lawsuit, the attorney general - aligned with the former president who is running for US Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "remove any promotional materials" that states acetaminophen is reliable for pregnant women.

The court case mirrors the concerns of a group of parents of minors with autism spectrum disorder and ADHD who sued the producers of Tylenol in two years ago.

Judicial authorities dismissed the case, saying investigations from the plaintiffs' authorities was lacking definitive proof.